Therapeutic Targeting of Epigenetic Components in Amyotrophic Lateral Sclerosis (ALS)

E-ISSN： 1875-533x|21|31|3576-3582

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.31, 2014-10, pp. : 3576-3582

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic advances in amyotrophic lateral sclerosis

By Louvel E. Hugon J. Doble A.

Trends in Pharmacological Sciences, Vol. 18, Iss. 6, 1997-06 ,pp. : 196-203

Elsevier

Access to resources Recommend Favorite

Therapeutic developments in amyotrophic lateral sclerosis

By Lai E.C.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 4, 1999-04 ,pp. : 347-361

Informa Healthcare

Access to resources Recommend Favorite

Targeting Astrocytes for Treatment in Amyotrophic Lateral Sclerosis

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 5037-5044

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis

By Corona Juan C Tovar-y-Romo Luis B Tapia Ricardo

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 11, 2007-11 ,pp. : 1415-1428

Informa Healthcare

Access to resources Recommend Favorite

New therapeutic targets for amyotrophic lateral sclerosis

By Kuzma-Kozakiewicz Magdalena Kwiecinski Hubert

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 2, 2011-02 ,pp. : 127-143

Informa Healthcare

Access to resources Recommend Favorite